NGS Discovery Pools enable larger custom panels and low sample numbers to speed up discovery
CORALVILLE, IA (October 17, 2019)
– Integrated DNA Technologies (IDT)
, a leading genomics solutions provider, launches an affordable, rapid and flexible solution for targeted next generation sequencing (NGS) at the ASHG 2019 Annual Meeting, Houston (booth 520). NGS Discovery Pools
are high quality, individually synthesized, 5’‑biotinylated oligo pools designed to enable researchers to rapidly build custom panels at a fraction of the cost compared to conventional panels – making NGS accessible to more stages of research and speeding up projects.
Dr. Mirna Jarosz, Director of NGS Business Development at IDT, will be giving a presentation on the NGS Discovery Pools on Friday, October 18th, at the ASHG. She commented, “At IDT, we understand that for scientists the difference between waiting days versus weeks for high quality reagents can mean everything. In our continued mission to exceed the needs of researchers, we are pleased to launch NGS Discovery Pools. These probes leverage the same high quality platform as our popular and trusted xGen® Lockdown® Probes
and arrive in a matter of days for a fraction of the cost. This will enable our customers to use our high quality capture technology for smaller projects and in earlier stages where content may still be changing, allowing for a smooth transition to Lockdown Probes as projects are scaled up and validated for clinical use. With this launch, we’re pleased to now be able to offer solutions for the whole precision medicine journey, from discovery to diagnostics.”
IDT’s xGen Lockdown Probes are already the highest quality solution for target capture, trusted for clinical sequencing globally. The new NGS Discovery Pools offer the quality of individual synthesis at the speed and scale needed for discovery in precision medicine. NGS Discovery Pools enable rapid prototyping which can then be built out into high volume projects with Lockdown Probes.
Jarosz added, “We’re excited to bring NGS Discovery Pools to market as they are really going to open up NGS. They are an ideal tool for minimal residual disease testing in solid tumors, where small patient-specific panels delivered within days will enable the highest levels of sensitivity required for monitoring therapeutic response.”
IDT leverages its expertise in oligo manufacturing, combined with its proprietary production platform, to permit high quality synthesis of custom capture probes that are never subjected to the bias and errors that come with amplification. The custom NGS Discovery Pools work straight out of the box, thanks to the 30 years of quality control that has gone into building the best DNA synthesis platforms in the world.
IDT technical experts will be on hand at booth 520 at ASHG 2019 to provide more information on the new NGS Discovery Pools and answer any questions.
IDT is an operating company within Danaher Corporation’s (NYSE: DHR) $6.5B Life Sciences platform. For more information, please visit www.idtdna.com
Follow IDT on twitter @idtdna
for real-time updates and insights.
Integrated DNA Technologies, Inc. (IDT)
develops, manufactures, and markets nucleic acid products for the life sciences industry in the areas of academic and commercial research, agriculture, medical diagnostics, and pharmaceutical development. IDT has developed proprietary technologies for genomics applications such as next generation sequencing, CRISPR genome editing, synthetic biology, digital PCR, and RNA interference. Through its GMP services, IDT manufactures products used in diagnostic tests for many forms of cancer and most inherited and infectious diseases. IDT is widely recognized as the industry leader in custom nucleic acid manufacture, serving over 120,000 life sciences researchers. IDT has its manufacturing headquarters in Coralville, Iowa, USA, with additional manufacturing sites in San Diego, California, USA; Leuven, Belgium; and Singapore.
Manager of Brand & Public Relations
Integrated DNA Technologies
About Danaher Corporation
is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, including IDT, Danaher’s globally diverse team of approximately 71,000 associates is united by a common culture and operating system, the Danaher Business System, and our Shared Purpose, Helping Realize Life’s Potential. For more information, please visit www.danaher.com